AroCell
AroCell: FDA filing – earlier than expected (Redeye)

2020-05-26 15:05
Earlier this morning AroCell communicated the positive news that the company has submitted its FDA filing for TK210 ELISA. Previously, we expected the filing to take place in H1 2021 and view the filing as an important catalyst, further demonstrating AroCell to be on track with the coming commercialization of its immunoassay.

info@redeye.se (Redeye.se)
Redeye AB - Redeye.se

AroCell - I dag

{point.key}

Marknadsöversikt

Stockholmsbörsen, OMXS30

I dag
-
Senast
-
{point.key}

Världsindex

Index +/- % Senast
DAX - -
Hang Seng - -
Nikkei - -

Valutor

Valuta +/- % Senast
USD/SEK - -
EUR/SEK - -
GBP/SEK - -
EUR/USD - -

Räntor

Ränta +/- % Senast
5-års ränta - -
10-års ränta - -

Råvaror

Råvara +/- % Senast
Guld - -
Silver - -
Koppar - -